mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |